Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Gelteq Ltd GELS

Healthcare Drug Manufacturers - Specialty & Generic
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia. see more

Current News (NDAQ:GELS)

Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq's Nutritional Product Expansion into China

GlobeNewswire 1 day ago

Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform

GlobeNewswire 5 days ago

Gelteq to Present at Investor Summit Virtual on December 9, 2025

GlobeNewswire 8 days ago

Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform

GlobeNewswire November 24, 2025

Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform

GlobeNewswire October 23, 2025

Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound

GlobeNewswire October 9, 2025

Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner

GlobeNewswire September 12, 2025

Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market

GlobeNewswire September 5, 2025

Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs

ACCESS Newswire September 4, 2025
View More News ››

Opinion & Analysis (NDAQ:GELS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:GELS)

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - November 24, 2025

$GELS + $HYEX = www.GutStraw com

$GELS Gelteq Expands U.S. Operations with $HYEX Healthy Extracts Inc. as North American Fulfillment Partner Major commercial...
CashSeeker - June 10, 2025

Buy buddy buy because it's taking off this morning.Wow

And furthermore,you guys will be missing out on this stock, FOMO
coolfooldumbguy - April 22, 2025

Buy buddy buy.

Otherwise you guys out there will be left behind.
coolfooldumbguy - January 22, 2025
View more Bullboard ››

Nurcapital Capital Pool

Nurcapital Capital Pool

Nurcapital Corporation Ltd. is a Canada-based capital pool company. The Company is engaged in identifying and evaluating ...
View More »